Background illustration for clinical trials search

Paid Clinical Trials Connecticut

Discover 1,167 paid clinical trials in Connecticut. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
FeaturedActive & Responsive

Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin

for
Diabetes Mellitus, Type 2, Obesity
Location: New Bedford MA, East Greenwich RI, Bridgeport CT,

Sex: All

Age: 18 - 70+

Recruiting
FeaturedActive & Responsive

Weight Loss Studies for Adults With a BMI of 27+, Including People Managing Type 2 Diabetes or Sleep Apnea

for
Obesity, Overweight, Diabetes Mellitus, Type 2,
Location: East Greenwich RI, Waterbury CT, Morehead City NC,

Sex: All

Age: 18+

Recruiting
FeaturedActive & Responsive

Investigational Oral GLP-1 Pill Studies for Adults With Type 2 Diabetes and an A1C Between 7% and 10.5%

for
Diabetes Mellitus, Type 2
Location: New Bedford MA, Bridgeport CT, Brooklyn NY,

Sex: All

Age: 18+

Recruiting
FeaturedActive & Responsive

Investigational Oral GLP-1 Pill Study for Adults With Type 2 Diabetes and Heart Disease or Heart Risk Factors

for
Diabetes Mellitus, Type 2, Cardiovascular Diseases
Location: Bridgeport CT, Philadelphia PA, Norfolk VA,

Sex: All

Age: 18+

Recruiting
FeaturedActive & Responsive

Investigational Oral GLP-1 Pill Studies for Adults With Type 2 Diabetes Taking Only Metformin or No Diabetes Medicine

for
Diabetes Mellitus, Type 2
Location: Bridgeport CT, Brooklyn NY, Newport News VA, Bowie MD,

Sex: All

Age: 18+

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & ResponsiveNew

PET Imaging of the sigma1 Receptor in Healthy Adults

for
Healthy Control Subjects
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18 - 60

Code: NCT07915323

Phase 1, Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

for
Breast Neoplasms
Location: Rimouski, Boston MA, Quebec, Stony Brook NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312176

Phase 3, Recruiting
Active & Responsive

Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies

for
Multiple System Atrophy (MSA), Healthy Adult, Parkinson Disease
Location: New Haven CT
Sponsor: MODAG GmbH

Sex: All

Age: 50 - 70+

Code: NCT07640555

Early Phase 1, Recruiting
Active & Responsive

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

for
Primary Myelofibrosis (PMF),
Location: New Haven CT, New York NY, Albany NY,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07357727

Phase 3, Recruiting
Active & Responsive

Driving Simulator Training For Adults With Acquired Brain Injuries

for
Acquired Brain Injury
Location: Fairfield CT
Sponsor: Sacred Heart University

Sex: All

Age: 18+

Code: NCT07378592

Recruiting
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Brewer ME, Scarborough ME, Peabody MA, Boston MA,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase 3, Recruiting
Active & Responsive

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

for
Hematopoietic Cell Transplantation Recipient, Leukemia,
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT00736749

Recruiting
Active & Responsive

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

for
Advanced Esophageal Adenocarcinoma,
Location: Westerly RI, Waterford CT, Guilford CT, Glastonbury CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06203600

Phase 2, Phase 3, Recruiting
Active & Responsive

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

for
Castration Levels of Testosterone,
Location: Brewer ME, Bath ME, Portland ME, Scarborough ME,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT03678025

Phase 3, Recruiting
Active & Responsive

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Waterford CT, New Haven CT, Stony Brook NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT04671667

Phase 2, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for
Crohn's Disease
Location: Kentville, Boston MA, Providence RI, Levis,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 16 - 70+

Code: NCT06430801

Phase 3, Recruiting
Active & Responsive

Speech Motor Learning and Retention (Aim 3)

for
Speech
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18 - 40

Code: NCT06492252

Recruiting
Active & Responsive

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

for
Alzheimers Disease, Dementia, Alzheimers Disease, Familial
Location: Providence RI, New Haven CT, Quebec, New York NY,
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06647498

Phase 2, Phase 3, Recruiting
Active & Responsive

Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD

for
Obsessive-Compulsive Disorder
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18 - 65

Code: NCT04131829

Phase 1, Phase 2, Recruiting
Active & Responsive

The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).

for
Intracranial Aneurysm
Location: Boston MA, New Haven CT, Stony Brook NY, New York NY,
Sponsor: Medtronic Neurovascular Clinical Affairs

Sex: All

Age: 18 - 70+

Code: NCT02998229

Recruiting

Popular cities in Connecticut

Connecticut stands out as a prime location for a wide variety of clinical trials, largely thanks to its robust healthcare system and renowned medical research institutions. Leading centers like Yale School of Medicine, UConn Health, and Jackson Laboratory for Genomic Medicine are at the forefront of groundbreaking studies in the state.

Combining a strong focus on innovation and precision medicine makes Connecticut an ideal destination for participants seeking advanced medical treatments and the opportunity to contribute to cutting-edge research.

Why choose Connecticut for clinical trials?

With a diverse and highly educated population, Connecticut offers distinct advantages for those participating in clinical trials, including the opportunity to enhance the reliability and depth of research findings. The vibrant population here makes clinical studies in Connecticut more comprehensive and representative.

By choosing to participate in a clinical trial in Connecticut, individuals contribute to groundbreaking medical research while benefiting from a well-established and supportive clinical research infrastructure, ultimately advancing healthcare for all.

Common conditions studied in Connecticut

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Connecticut